Evidence map›Paper›PMID 42550967›Full record

ArticleCancer discovery2026

Follicular Lymphoma Transformation is Characterized by Cytokine-associated Remodeling of Stromal and Macrophage Compartments.

Nicholas J Haradhvala, Stephanie Pei Tung Yiu, Laura Beckmann, Sam Sadigh, Zachary Leibowitz, Erik Landolsi, Santiago Rivero, Stephanie L Deng, Sabrina Hu, Mingzeng Zhang and 30 more

Abstract read
In one paragraph

Article in Cancer discovery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

40 authors.

Nicholas J HaradhvalaBroad Institute Cambridge, MA United States.ORCID 0000-0003-1113-3135
Stephanie Pei Tung YiuBeth Israel Deaconess Medical Center Boston United States.ORCID 0000-0002-1792-247X
Laura BeckmannDana-Farber Cancer Institute Boston, MA United States.ORCID 0000-0001-5207-8991
Sam SadighBrigham and Women's Hospital Boston United States.ORCID 0000-0003-2557-7415
Zachary LeibowitzDana-Farber Cancer Institute Boston, MA United States.ORCID 0009-0007-2498-2976
Erik LandolsiBroad Institute Cambridge, MA United States.ORCID 0000-0002-6639-1257
Santiago RiveroDana-Farber Cancer Institute Boston, MA United States.ORCID 0009-0003-0725-4441
Stephanie L DengYale School of Medicine New Haven, CT United States.ORCID 0000-0002-0943-1339
Sabrina HuDana-Farber Cancer Institute Boston, MA United States.ORCID 0009-0009-0381-1697
Mingzeng ZhangDana-Farber Cancer Institute Boston, MA United States.ORCID 0000-0001-6875-8940
Daniel FilipCentral European Institute of Technology - Masaryk University Czech Republic.ORCID 0000-0001-8717-5230
Amber PospistleBroad Institute United States.ORCID 0009-0008-0625-4411
Yao Yu YeoBeth Israel Deaconess Medical Center Boston United States.ORCID 0000-0002-7604-2296
Katie MaurerDana-Farber Cancer Institute Boston, MA United States.ORCID 0000-0002-4160-181X
Johan GustafssonBroad Institute Cambridge, Massachusetts United States.ORCID 0000-0001-5072-2659
Kai StewartBroad Institute Cambridge, MA United States.ORCID 0009-0006-4695-7950
Vignesh ShanmugamBrigham and Women's Hospital Boston, MA United States.ORCID 0000-0002-2005-9080
McKayla Van OrdenDana-Farber Cancer Institute Boston, MA United States.ORCID 0009-0008-6831-4707
Wesley S LuWeill Cornell Medicine New York, New York United States.ORCID 0009-0007-5584-041X
Shuqiang LiDana-Farber Cancer Institute Boston, MA United States.ORCID 0000-0001-9106-6141
Kenneth J LivakDana-Farber Cancer Institute Boston, MA United States.ORCID 0000-0001-9105-5856
Huaying QiuBeth Israel Deaconess Medical Center Boston United States.ORCID 0009-0006-7163-2269
Ankit BasakMassachusetts Institute of Technology Cambridge, MA United States.ORCID 0000-0001-9240-7147
Alex K ShalekMassachusetts Institute of Technology Cambridge, MA United States.ORCID 0000-0001-5670-8778
Brian P DanyshBroad Institute of MIT and Harvard Cambridge, MA United States.ORCID 0000-0001-6839-6337
Mikaela McDonoughDana-Farber Cancer Institute Boston, MA United States.
Satyen H GohilBroad Institute of MIT and Harvard Cambridge, MA United States.ORCID 0000-0003-0484-991X
Yue RenDana-Farber Cancer Institute Boston United States.ORCID 0009-0003-4777-3342
Yinglu ZhouDana-Farber Cancer Institute Boston United States.ORCID 0000-0001-6276-635X
Donna S NeubergDana-Farber Cancer Institute Boston, MA United States.ORCID 0000-0003-2566-3145
Svitlana TyekuchevaDana-Farber Cancer Institute Boston United States.ORCID 0000-0002-3119-6507
Scott J RodigDana-Farber Cancer Institute Boston, MA United States.ORCID 0000-0003-1761-9769
Eric D JacobsenDana-Farber Cancer Institute Boston, Massachusetts United States.ORCID 0000-0003-3014-0023
Marek MrazMasaryk University Brno Czech Republic.ORCID 0000-0001-6975-8838
Mark A MurakamiDana-Farber Cancer Institute Boston, MA United States.ORCID 0000-0001-9520-2876
Habibe KurtBrigham and Women's Hospital Boston United States.ORCID 0000-0002-4579-3003
Catherine J WuDana-Farber Cancer Institute Boston, MA United States.ORCID 0000-0002-3348-5054
Gad GetzBroad Institute Cambridge, MA United States.ORCID 0000-0002-0936-0753
Sizun JiangBeth Israel Deaconess Medical Center Boston United States.ORCID 0000-0001-6149-3142
Erin M ParryDana-Farber Cancer Institute Boston, MA United States.ORCID 0000-0002-3382-9769

Funding

Cancer Immune Monitoring and Analysis CenterU24CA224331 · NCI · DANA-FARBER CANCER INST · PI FRANK S HODI, Catherine Ju-Ying Wu · 2017 to 2026
$18.4M
Defining Mechanisms of Viral Persistence in Situ at the Single-Cell LevelR01AI149672 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI ESTES, JACOB D · 2020 to 2024
$4.0M
Spatial-Temporal Dissection of Stratified Host Tissue Responses to Severe acute respiratory syndrome-related coronaviruses in situ to Understand Intra-host PathogenesisDP2AI171139 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI Sizun Jiang · 2022 to 2026
$2.3M
Single cell investigation of co-evolution in cancer cells and host cell immune microenvironmentR50CA251956 · NCI · DANA-FARBER CANCER INST · PI Shuqiang Li · 2020 to 2026
$1.4M
Dissecting Orchestrated Immune Responses to Glioblastoma within the Native Tissue Microenvironment to Improve Treatment OutcomesR01NS139479 · NINDS · BETH ISRAEL DEACONESS MEDICAL CENTER · PI VASSILIKI A BOUSSIOTIS, Alain Charest · 2025 to 2026
$1.4M
Statistical Power Analysis Framework for Multi-Sample and Cross-Platform Spatial Omics ExperimentsR01GM152585 · NIGMS · OHIO STATE UNIVERSITY · PI Dongjun Chung, Qin Ma · 2024 to 2026
$1.2M
Tracing the Evolution of Chronic Lymphocytic Leukemia to Richter's Syndrome: Defining TransformationK08CA270085 · NCI · DANA-FARBER CANCER INST · PI Erin M Parry · 2022 to 2026
$945k
NCI NIH HHS K08 CA270085NCI NIH HHS R50 CA251956NCI NIH HHS U24 CA224331NIAID NIH HHS DP2 AI171139NIAID NIH HHS R01 AI149672NIGMS NIH HHS R01 GM152585NINDS NIH HHS R01 NS139479Wellcome Trust
6 · The paper itself

Abstract

Across cancer, one of the most frequent examples of histologic transformation is the evolution of follicular lymphoma (FL) to an aggressive large cell lymphoma. Despite recent progress, understanding of the molecular and cellular underpinnings of transformation remains incomplete. Here, we dissect the interplay of tumor and microenvironment cell populations across transformation through a multimodal investigation of 95 FL and transformed FL (tFL) samples, including single-cell and bulk RNA-sequencing alongside spatial transcriptomics and proteomics, and validate findings across independent FL-tFL pairs. Upon transformation, fibroblasts and GPNMB+ macrophages increase while lymph-node organizing follicular dendritic and CCL21+ fibroblastic reticular cells were lost, resulting in an altered spatial distribution of cytokines that impacts T cell infiltration and macrophage differentiation and function. Secreted stromal and macrophage signals were further evident by non-invasive plasma proteomics. Taken together, our data reveal expansion of macrophages and fibroblasts as key features of transformation with potential diagnostic and therapeutic implications.

Identifiers

PMID42550967
PMCPMC13552640

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.